Financials
- Market Capitalization 53.04 M
- Employee 17
- Founded 2018
- CEO N/A
- Website www.instilbio.com
- Headquarter New York, United States
- FIGI BBG00ZGYN521
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.18
Fiyat/satışlar oranı
6.16
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4253 | BYSI BeyondSpring, Inc. - Ordinary Shares | 1.33 USD | 0.00% | -18.90% | -17.39% | -41.41% | 54.69 M USD | ||
| 4261 | INMB INmune Bio Inc. - Common stock | 2.02 USD | +8.60% | +16.09% | +56.59% | -1.94% | 53.70 M USD | ||
| 4272 | XLO Xilio Therapeutics, Inc. - Common Stock | 9.03 USD | -2.27% | -1.20% | +6.24% | +1136.99% | 52.22 M USD | ||
| 4279 | MCRB Seres Therapeutics, Inc. - Common Stock | 5.34 USD | -4.98% | -32.49% | -5.32% | -35.12% | 51.19 M USD |